(British Society of Gastroenterology)
- GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism
- Retraction: Unleashing the potential of exosome ncRNAs for early gastric cancer detection--a critical appraisal of machine learning approaches
- Targeting MXD1 sensitises pancreatic cancer to trametinib
- Perspective on enhancing CRC risk prediction
- Response to the letter to the editor 'revisiting lipid dysregulation in colorectal cancer: critical appraisal of pro-inflammatory bias and therapeutic implications
- Stressed hepatocyte sustains alcohol-associated hepatitis progression by producing leukocyte cell-derived chemotaxin 2
- GI highlights from the literature
- Beyond the guideline: lessons in leadership, limits and legacy from the BSG IBD process
- Histology of subepithelial lesions (SELs) in the gastrointestinal tract-resected endoscopic: a database study of 4901 patients
- Much ado about EoE
- Putting the best foot forward: rethinking the paradigms in ASUC
- Alcohol exhibits contrasting effects on CD8+ T cells in the gut and liver in alcohol-associated liver disease
- Correction: pancreatic STAT5 activation promotes KrasG12D-induced and inflammation-induced acinar-to-ductal metaplasia and pancreatic cancer
- Correction: Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU
- Gene score to quantify systemic inflammation in patients with acutely decompensated cirrhosis
Click to rate this post!
[Total: 1 Average: 5]
